New ALS drug trial seeks safer treatment, not a cure
Disease control
Ongoing
This early-stage study tests the safety of a new drug called QRL-201 in 69 people with ALS, a nerve disease that weakens muscles. Participants receive either the drug or a placebo to check for side effects. The goal is to see if QRL-201 is safe enough for further testing, not to …
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Disease control
Last updated May 17, 2026 12:24 UTC